Cite
HARVARD Citation
Criner, G. et al. (n.d.). 325 Immunotherapy with B cell activating antibody CPI-006 in patients (pts) with mild to moderate COVID-19 stimulates anti-SARS-CoV-2 antibody response, memory B cells and memory T effector cells. Journal for immunotherapy of cancer. p. A351. [Online].